IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 106
Titolo Tipologia Data di pubblicazione Autore(i) File
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays? 1.2 Recensione in rivista 2022 Garufi, G.; Carbognin, L.; Arcana, C.; Parola, S.; Ventriglia, A.; Doronzo, A.; Garutti, M.; Orlandi, A.; Palazzo, A.; Fabi, A.; Bria, E.; Tortora, G.; Arpino, G.; Giuliano, M.; Del Mastro, L.; De Laurentiis, M.; Puglisi, F.
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 1.1 Articolo in rivista 2020 Carbognin, Luisa; Simbolo, Michele; Caliò, Anna; Vicentini, Caterina; Delfino, Pietro; Sperduti, Isabella; Fassan, Matteo; Schettini, Francesco; Dieci, Maria Vittoria; Griguolo, Gaia; Pilotto, Sara; Fiorio, Elena; Arpino, Grazia; Guarneri, Valentina; De Placido, Sabino; Conte, Pierfranco; Manfrin, Erminia; Brunelli, Matteo; Scambia, Giovanni; Scarpa, Aldo; Tortora, Giampaolo; Bria, Emilio
Altri tumori gastrointestinali 2.1 Contributo in volume (Capitolo o Saggio) 2011 Tortora, Giampaolo; Palmieri, Giovannella; Carlomagno, Chiara
Paraneoplastic sensitive neuropathy associated with anti-hu antibodies in a neuroendocrine tumor of duodenum: a case report. 1.1 Articolo in rivista 2010 Nappi, Lucia; Formisano, Luigi; Damiano, Vincenzo; Matano, Elide; Bianco, Roberto; Tortora, Giampaolo
A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action 1.1 Articolo in rivista 2009 Damiano, Vincenzo; Bianco, Roberto; Garofalo, Sonia; Rosa, Roberta; R., Caputo; Gelardi, Teresa; G., Merola; Racioppi, Luigi; Garbi, Corrado; Tortora, Giampaolo
EGFR antagonists in cancer treatment. 1.1 Articolo in rivista 2008 Ciardiello, F.; Tortora, Giampaolo
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells. 1.1 Articolo in rivista 2008 Cascone, T; Morelli, Mp; Morgillo, F; Kim, Wy; Rodolico, G; Pepe, Stefano; Tortora, Giampaolo; Berrino, L; Lee, Hy; Heymach, Jv; Ciardiello, F.
The use of xenograft models for the selection of cancer treatments with the EGFR as an example. 1.1 Articolo in rivista 2008 Troiani, T; Schettino, C; Martinelli, E; Morgillo, F; Tortora, Giampaolo; Ciardiello, F.
LY2109761, a Novel Transforming Growth Factor ß Receptor type I and II dual inhibitor, as a Therapeutic Approach to Suppressing Pancreatic Cancer Metastasis. 1.1 Articolo in rivista 2008 Melisi, D; Ishiyama, S; Sclabas, Gm; Fleming, B. J.; Xia, Q; Tortora, Giampaolo; Abbruzzese, Jl; Chiao, P. J.
VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells. 1.1 Articolo in rivista 2008 Bianco, Roberto; Rosa, R; Damiano, V; Daniele, G; Gelardi, T; Garofalo, S; Tarallo, V; De Falco, S; Melisi, D; Benelli, R; Albini, A; Ryan, A; Ciardiello, F; Tortora, Giampaolo
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs 1.1 Articolo in rivista 2008 Gelardi, Teresa; Caputo, R; Damiano, Vincenzo; Daniele, Gennaro; Pepe, Stefano; Ciardiello, F; Lahn, M; Bianco, Roberto; Tortora, Giampaolo
Combined targeting of EGFR and VEGF-dependent pathways: rationale, preclinical studies and clinical applications 1.1 Articolo in rivista 2008 Tortora, Giampaolo; Ciardiello, F; Gasparini, G.
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumors sensitive and resistant to anti-EGFR drugs 1.1 Articolo in rivista 2008 Bianco, Roberto; Garofalo, S; Rosa, R; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo
EGFR-targeting agents in oncology 1.2 Recensione in rivista 2008 Garofalo, Sonia; Rosa, Roberta; Bianco, Roberto; Tortora, Giampaolo
Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. 1.1 Articolo in rivista 2007 Rosano, L; DI CASTRO, V; Spinella, F; Tortora, Giampaolo; Nicotra, Mr; Natali, Pg; Bagnato, A.
The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy. 1.1 Articolo in rivista 2007 Tortora, Giampaolo; Gelardi, T; Ciardiello, F; Bianco, Roberto
Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies. 1.1 Articolo in rivista 2007 Tortora, Giampaolo; Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Mccubrey, Ja; Ricciardi, Mr; Ciuffreda, L; Cognetti, F; Tafuri, A; Milella, M.
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy. 1.1 Articolo in rivista 2007 Morgillo, F; Bareschino, Ma; Bianco, Roberto; Tortora, Giampaolo; Ciardiello, F.
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. 1.1 Articolo in rivista 2007 Tabernero, J; Van Cutsem, E; Díaz Rubio, E; Cervantes, A; Humblet, Y; André, T; Van Laethem, Jl; Soulié, P; Casado, E; Verslype, C; Sastre Valera, J; Tortora, Giampaolo; Ciardiello, F; Kisker, O; de Gramont, A.
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling. 1.1 Articolo in rivista 2007 Bianco, Roberto; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo
Mostrati risultati da 1 a 20 di 106
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile